about
Short communication: Molecular epidemiology, phylogeny, and phylodynamics of CRF63_02A1, a recently originated HIV-1 circulating recombinant form spreading in Siberia.Polyepitope protein incorporated the HIV-1 mimotope recognized by monoclonal antibody 2G12.Selection of peptide mimics of HIV-1 epitope recognized by neutralizing antibody VRC01.Design and evaluation of optimized artificial HIV-1 poly-T cell-epitope immunogensNovel approaches in polyepitope T-cell vaccine development against HIV-1.Peptide-MHC multimer-based monitoring of CD8 T-cells in HIV-1 infection and AIDS vaccine development.Design of Polyepitope DNA Vaccine against Breast Carcinoma Cells and Analysis of Its Expression in Dendritic Cells.Rational design based synthetic polyepitope DNA vaccine for eliciting HIV-specific CD8+ T cell responses.Visualization of CombiHIVvac Vaccine Particles Using Electron Microscopy.Attenuated Salmonella enteritidis E23 as a vehicle for the rectal delivery of DNA vaccine coding for HIV-1 polyepitope CTL immunogen.Construction of artificial virus-like particles exposing HIV epitopes, and the study of their immunogenic properties.Localization of the amino terminus of the hepatitis B virus core antigen within the core particle.P19-04. A synergistic effect of a combined bivalent DNA-protein anti-HIV-1 vaccine containing multiple T- and B-cell epitopes of HIV-1 proteins.P05-02. Including peptides-mimotopes of neutralizing 2F5 epitope of HIV-1 into artificial peptide TBI – vaccine candidate.P19-13. Recombinant proteins carrying peptide mimics of HIV-1.Erratum to: Design of Polyepitope DNA Vaccine against Breast Carcinoma Cells and Analysis of Its Expression in Dendritic Cells.P19-36. Preclinical study of CombiHIVvac vaccineDevelopment of Phage Display Technology: A Bibliometric AssessmentDesign of immunogens as components of a new generation of molecular vaccinesInsertion of foreign epitopes in HBcAg: how to make the chimeric particle assembleConstruction of an artificial immunogen, a candidate DNA vaccine encoding multiple CTL epitopes of HIV-1A synergistic effect of a combined bivalent DNA-protein anti-HIV-1 vaccine containing multiple T- and B-cell epitopes of HIV-1 proteinsArtificial Anti-HIV-1 Immunogen Comprising Epitopes of Broadly Neutralizing Antibodies 2F5, 10E8, and a Peptide Mimic of VRC01 Discontinuous Epitope
P50
Q34116894-7D2B9D1E-CE9C-4AFB-9162-292885A306D7Q34160874-299D1503-C0DF-4C18-A588-1EC7022D4963Q35191547-FE2E7F49-01B1-418F-9E1F-898341E9EA70Q35192275-DA1269B1-E398-4AAB-9FFE-317A5E2C0195Q38168900-9EA05A07-F6B0-4643-9225-CAD36282B21FQ38265356-D8D170B7-EDA3-4831-B8CC-F8C24BDEDD20Q38791070-516E5F87-61F2-48D0-8510-8B71AF2D7CBDQ39734252-EA514EB7-F6B8-4159-BD48-CC332403B97BQ40416352-B37EC8BD-8448-4B36-973A-240BABC7893CQ41834074-16A93872-162D-4E21-B361-569DBE0CC763Q45729525-6070761C-57F9-414E-B045-798FE40A52B0Q45758135-0DD474FD-A934-4D9A-8F03-D69ADC7E3F01Q46424565-991831D7-D783-4479-BC24-F5955E14EC61Q46552135-63A608C0-E86B-4790-969C-9925FC19EE48Q46812396-60DE7CDC-F409-44CB-A56F-3118710C37ACQ50875420-B4E57247-AC66-4488-BA7F-0D41658E2E65Q59219893-C45703F9-2DA9-4185-848F-9195D7B0E30FQ59839570-53E1262F-70A0-4D24-B35B-1AA3D8CA1EA6Q71284351-1EA6D6F8-C7B4-4A57-851F-1AB8BE8C24CBQ74194187-E7B68DC3-D1ED-43E6-A8DD-A6A1B9761458Q80340361-38FEAA29-C674-4FFA-A5C0-AD82BEF2B37EQ81297616-1C77DC39-A7F5-4427-AE2D-A31D45498DE4Q92478855-652C729F-79FC-436C-A577-D03A45AD45FE
P50
description
researcher ORCID ID = 0000-0003-4365-8809
@en
wetenschapper
@nl
name
Larisa Karpenko
@ast
Larisa Karpenko
@en
Larisa Karpenko
@es
Larisa Karpenko
@nl
Larissa Iwanowna Karpenko
@de
Лариса Ивановна Карпенко
@ru
type
label
Larisa Karpenko
@ast
Larisa Karpenko
@en
Larisa Karpenko
@es
Larisa Karpenko
@nl
Larissa Iwanowna Karpenko
@de
Лариса Ивановна Карпенко
@ru
altLabel
Larisa Ivanovna Karpenko
@en
Larissa Karpenko
@de
prefLabel
Larisa Karpenko
@ast
Larisa Karpenko
@en
Larisa Karpenko
@es
Larisa Karpenko
@nl
Larissa Iwanowna Karpenko
@de
Лариса Ивановна Карпенко
@ru
P106
P1153
7005000410
P21
P31
P496
0000-0003-4365-8809